Sartorius


18/11/22 -"We trim our outlook to reflect the softer than expected development in the BPS business, which is facing a double-whammy of declining COVID-19-related business as well as customer destocking as ..."

Pages
66
Language
English
Published on
18/11/22
You may also be interested by these reports :
10/05/24
While the 2023 EPS benefitted from material deferred tax income, we have moderated our earnings estimates for 2024-25 owing to high interest rates ...

10/05/24
Fresenius reported Q1 figures that exceeded the consensus, with revenues increasing by 0.3%, adjusted EBIT by 4.5%, net income from continuing ...

09/05/24
Smith & Nephew reported marginally softer than expected Q1 24 numbers. The weakness was largely attributable to US implants and areas within wound ...

08/05/24
CZM reported soft Q2 results with both sales and adjusted EBIT missing the street’s expectations. The mid-single-digit sales decline was due to ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO